170 related articles for article (PubMed ID: 25230787)
1. Associations between the cytotoxic T lymphocyte antigen 4 polymorphisms and risk of bone sarcomas.
Fan C; Zhao X; Xu Z
Tumour Biol; 2015 Jan; 36(1):227-31. PubMed ID: 25230787
[TBL] [Abstract][Full Text] [Related]
2. Association of Cytotoxic T-lymphocyte Antigen-4 Polymorphisms with Malignant Bone Tumor Risk: A Meta-analysis.
Zhang C; Hou WH; Ding XX; Wang X; Zhao H; Han XW; Wang WJ
Asian Pac J Cancer Prev; 2016; 17(8):3785-91. PubMed ID: 27644617
[TBL] [Abstract][Full Text] [Related]
3. Significant association between cytotoxic T lymphocyte antigen 4 +49G>A polymorphism and risk of malignant bone tumors.
Yu F; Miao J
Tumour Biol; 2013 Dec; 34(6):3371-5. PubMed ID: 23900675
[TBL] [Abstract][Full Text] [Related]
4. Polymorphisms in the cytotoxic T-lymphocyte antigen 4 gene and acute rejection risk in transplant recipients.
Zhu CL; Huang Q; Liu CH; Xie F
Mol Biol Rep; 2012 Sep; 39(9):8701-8. PubMed ID: 22711308
[TBL] [Abstract][Full Text] [Related]
5. Association between CTLA-4 60G/A and -1661A/G polymorphisms and the risk of cancers: a meta-analysis.
Yan Q; Chen P; Lu A; Zhao P; Gu A
PLoS One; 2013; 8(12):e83710. PubMed ID: 24376736
[TBL] [Abstract][Full Text] [Related]
6. Association between cytotoxic T lymphocyte antigen-4 +49A/G, -1722T/C, and -1661A/G polymorphisms and cancer risk: a meta-analysis.
Geng R; Song F; Yang X; Sun P; Hu J; Zhu C; Zhu B; Fan W
Tumour Biol; 2014 Apr; 35(4):3627-39. PubMed ID: 24307627
[TBL] [Abstract][Full Text] [Related]
7. Polymorphisms in the cytotoxic T-lymphocyte antigen 4 gene and cancer risk: a meta-analysis.
Zhang Y; Zhang J; Deng Y; Tian C; Li X; Huang J; Fan H
Cancer; 2011 Sep; 117(18):4312-24. PubMed ID: 21387262
[TBL] [Abstract][Full Text] [Related]
8. Cytotoxic T-lymphocyte antigen-4 polymorphisms and susceptibility to osteosarcoma.
Liu Y; He Z; Feng D; Shi G; Gao R; Wu X; Song W; Yuan W
DNA Cell Biol; 2011 Dec; 30(12):1051-5. PubMed ID: 21612409
[TBL] [Abstract][Full Text] [Related]
9. Lack of association between cytotoxic T-lymphocyte antigen-4 -318C/T polymorphism and cancer risk: a meta-analysis of case-control studies.
Xia W; Shi R; Zheng WL; Ma WL
Technol Cancer Res Treat; 2013 Dec; 12(6):565-74. PubMed ID: 23745791
[TBL] [Abstract][Full Text] [Related]
10. Cytotoxic T-lymphocyte antigen-4 genetic variants and risk of Ewing's sarcoma.
Feng D; Yang X; Li S; Liu T; Wu Z; Song Y; Wang J; Gao W; Huang Q; Huang W; Zheng W; Xiao J
Genet Test Mol Biomarkers; 2013 Jun; 17(6):458-63. PubMed ID: 23480667
[TBL] [Abstract][Full Text] [Related]
11. [Association between cytotoxic T lymphocyte protein-4 polymorphisms and non-Hodgkin's lymphoma risk: a meta-analysis].
Yi B; Pei Y; Wang C; Jiang Y
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Aug; 32(8):1099-104. PubMed ID: 27412943
[TBL] [Abstract][Full Text] [Related]
12. Comprehensive evaluation of the cytotoxic T-lymphocyte antigen-4 gene polymorphisms in risk of bone sarcoma.
Liu S; Geng P; Cai X; Wang J
Genet Test Mol Biomarkers; 2014 Aug; 18(8):574-9. PubMed ID: 25000484
[TBL] [Abstract][Full Text] [Related]
13. The associations between the polymorphisms in the CTLA-4 gene and the risk of Graves' disease in the Chinese population.
Du L; Yang J; Huang J; Ma Y; Wang H; Xiong T; Xiang Z; Zhang Y; Huang J
BMC Med Genet; 2013 Apr; 14():46. PubMed ID: 23597029
[TBL] [Abstract][Full Text] [Related]
14. Lack of association between CTLA-4 +49A/G and -318C/T polymorphisms and Behçet's disease risk: a meta-analysis.
Zhang YJ; Xu WD; Duan ZH; Liu SS; Pan HF; Ye DQ
Clin Exp Rheumatol; 2012; 30(3 Suppl 72):S46-50. PubMed ID: 23010350
[TBL] [Abstract][Full Text] [Related]
15. CTLA-4 polymorphisms and systemic lupus erythematosus (SLE): a meta-analysis.
Zhai JX; Zou LW; Zhang ZX; Fan WJ; Wang HY; Liu T; Ren Z; Dai RX; Ye D
Mol Biol Rep; 2013 Sep; 40(9):5213-23. PubMed ID: 23922195
[TBL] [Abstract][Full Text] [Related]
16. Association of cytotoxic T lymphocyte antigen-4 +49A/G polymorphism and cancer risk: An updated meta-analysis.
Gao X; Zhang S; Qiao X; Yao Y; Wang L; Dong D; Ma X; Wang T
Cancer Biomark; 2014; 14(4):287-94. PubMed ID: 24934372
[TBL] [Abstract][Full Text] [Related]
17. Association among cytotoxic T-lymphocyte antigen 4 gene, rs231775 polymorphism, and recurrent pregnancy loss risk.
Song Y; Chen Y; Xu Q
Biosci Rep; 2019 Feb; 39(2):. PubMed ID: 30578376
[TBL] [Abstract][Full Text] [Related]
18. The association between CTLA-4 (+49 A/G) polymorphism and susceptibility to ankylosing spondylitis: a meta-analysis.
Wu J; Zhang L; Zhou Y
Int J Rheum Dis; 2016 Dec; 19(12):1237-1243. PubMed ID: 26176417
[TBL] [Abstract][Full Text] [Related]
19. Polymorphisms in the CTLA-4 gene and rheumatoid arthritis susceptibility: a meta-analysis.
Li X; Zhang C; Zhang J; Zhang Y; Wu Z; Yang L; Xiang Z; Qi Z; Zhang X; Xiao X
J Clin Immunol; 2012 Jun; 32(3):530-9. PubMed ID: 22354566
[TBL] [Abstract][Full Text] [Related]
20. CTLA-4 +49 A/G and -318 C/T polymorphisms and susceptibility to multiple sclerosis: a meta-analysis.
Gyu Song G; Ho Lee Y
Immunol Invest; 2013; 42(5):409-22. PubMed ID: 23802171
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
